· Pfizer Inc. announced the availability of its rheumatoid arthritis biosimilar, RUXIENCE, in July 2021.
· Pfizer Inc. disclosed in September 2021 that it would acquire Amplyx Pharmaceuticals, a privately held business that specializes in creating medications for life-threatening infections.
Author Credits: Abhishek Verma
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?